Literature DB >> 25003266

Low dose capsule based 13c-urea breath test compared with the conventional 13c-urea breath test and invasive tests.

Rejane Mattar1, Cibele Aparecida Villares1, Priscila Faria França Marostegam2, Cleuber Esteves Chaves2, Vanusa Barbosa Pinto2, Flair José Carrilho1.   

Abstract

CONTEXT: One of the limitations of 13C-urea breath test for Helicobacter pylori infection diagnosis in Brazil is the substrate acquisition in capsule presentation.
OBJECTIVES: The purpose of this study was to evaluate a capsule-based 13C-urea, manipulated by the Pharmacy Division, for the clinical practice.
METHODS: Fifty patients underwent the conventional and the capsule breath test. Samples were collected at the baseline and after 10, 20 and 30 minutes of 13C-urea ingestion. Urease and histology were used as gold standard in 83 patients.
RESULTS: In a total of 50 patients, 17 were positive with the conventional 13C-urea (75 mg) breath test at 10, 20 and 30 minutes. When these patients repeated breath test with capsule (50 mg), 17 were positive at 20 minutes and 15 at 10 and 30 minutes. The relative sensitivity of 13C-urea with capsule was 100% at 20 minutes and 88.24% at 10 and at 30 minutes. The relative specificity was 100% at all time intervals. Among 83 patients that underwent capsule breath test and endoscopy the capsule breath test presented 100% of sensitivity and specificity.
CONCLUSIONS: Capsule based breath test with 50 mg 13C-urea at twenty minutes was found highly sensitive and specific for the clinical setting.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25003266     DOI: 10.1590/s0004-28032014000200012

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  6 in total

1.  PREVALENCE OF HELICOBACTER PYLORI TEN YEARS AGO COMPARED TO THE CURRENT PREVALENCE IN PATIENTS UNDERGOING UPPER ENDOSCOPY.

Authors:  Sandra Frugis; Nicolau Gregori Czeczko; Osvaldo Malafaia; Artur Adolfo Parada; Paula Bechara Poletti; Thiago Festa Secchi; Matheus Degiovani; Alécio Rampanazzo-Neto; Mariza D D Agostino
Journal:  Arq Bras Cir Dig       Date:  2016 Jul-Sep

2.  Breath tests for gastrointestinal diseases - will it be safe to conduct breath tests after the COVID-19 pandemic?

Authors:  Rejane Mattar
Journal:  Clinics (Sao Paulo)       Date:  2020-06-22       Impact factor: 2.365

3.  Anti-Helicobacter pylori activities of FEMY-R7 composed of fucoidan and evening primrose extract in mice and humans.

Authors:  Tae-Su Kim; Ehn-Kyoung Choi; Jihyun Kim; Kyungha Shin; Sung-Pyo Lee; Youngjin Choi; Joseph H Jeon; Yun-Bae Kim
Journal:  Lab Anim Res       Date:  2014-09-29

Review 4.  Diagnosis of Helicobacter pylori: Changes towards the Future.

Authors:  Behnam Kalali; Luca Formichella; Markus Gerhard
Journal:  Diseases       Date:  2015-06-29

Review 5.  Non-invasive diagnostic tests for Helicobacter pylori infection.

Authors:  Lawrence Mj Best; Yemisi Takwoingi; Sulman Siddique; Abiram Selladurai; Akash Gandhi; Benjamin Low; Mohammad Yaghoobi; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15

6.  Performance of the 13C-urea breath test for the diagnosis of H. pylori infection using a substrate synthesized in Brazil: A preliminary study.

Authors:  Luiz Gonzaga Coelho; Carlos Roberto Sant'Ana; Ricardo Brandt de Oliveira; Raíra César E Cezar; Aline Cordeiro Campos de Araujo; Raisa Cristina Teodoro da Silva; Osmar Reni Trindade; Maria Clara Coelho; Eduardo Ferrioli; José Albertino Bendassolli
Journal:  Clinics (Sao Paulo)       Date:  2018-06-07       Impact factor: 2.365

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.